Generation of a TSC2 knockout embryonic stem cell line by CRISPR/ Cas9 editing

被引:0
|
作者
Zhang, Siyao [1 ,2 ]
Fan, Jiaqi [1 ,2 ]
Sun, Hairui [1 ,2 ]
Hao, Xiaoyan [1 ,2 ]
He, Yihua [2 ]
机构
[1] Capital Med Univ, Anzhen Hosp, Beijing 100029, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Maternal Fetal Med Ctr Fetal Heart Dis, Beijing 100029, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.scr.2024.103399
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Tuberous Sclerosis Complex (TSC) is a severe developmental disorder with various clinical effects, primarily caused by TSC2 gene mutations, often involving loss of function(Henske,et al., 2016).To explore role of TSC2 in human heart development, we successfully developed a TSC2 knockout (TSC2-/-) human embryonic stem cells (hESCs) line using CRISPR/Cas9 gene editing. This TSC2-/- hESC line maintained a normal karyotype, expressed pluripotency markers strongly, and could differentiate into all three germ layers in vivo. This cell line will be a valuable tool for future research on the role of TSC2 in heart development.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells
    Xu Wang
    Yang Zhao
    Zhan Wang
    Zhangcheng Liao
    Yushi Zhang
    Cell Biochemistry and Biophysics, 2022, 80 : 681 - 687
  • [42] An Efficient Method for Generation of Knockout Human Embryonic Stem Cells Using CRISPR/Cas9 System
    Bohaciakova, Dasa
    Renzova, Tereza
    Fedorova, Veronika
    Barak, Martin
    Kunova Bosakova, Michaela
    Hampl, Ales
    Cajanek, Lukas
    STEM CELLS AND DEVELOPMENT, 2017, 26 (21) : 1521 - 1527
  • [43] Generation of a BEST1 Pr-EGFP reporter human embryonic stem cell line via CRISPR/Cas9 editing
    Lu, Shuaiyan
    Chen, Ming
    Liu, Xiaoyu
    Li, Jiahang
    Liu, Hui
    Li, Shasha
    STEM CELL RESEARCH, 2025, 82
  • [44] Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system
    Luo, Qian
    Wei, Cong
    Long, Yan
    Zhang, Meng
    Shan, Wei
    Li, Honghu
    Cai, Shuyang
    Xu, Yulin
    Qian, Pengxu
    Huang, He
    STEM CELL RESEARCH, 2021, 53
  • [45] Establishment of a PPP2CA homozygous knockout human embryonic stem cell line via CRISPR/Cas9 system
    Ding, Tongbin
    Gao, Zhe
    Liu, Hang
    Li, Yuan
    Liu, Shichao
    Jian, Liguo
    STEM CELL RESEARCH, 2023, 67
  • [46] Generation of a homozygous P4HA2 knockout human embryonic stem cell line (FDCHDPe012-A) by CRISPR/Cas9 system
    You, Jie
    Ma, Shuangping
    Zhang, Haokun
    Chen, Ling
    STEM CELL RESEARCH, 2022, 64
  • [47] Generation of a homozygous CPAMD8 knockout human embryonic stem cell line (WAe009-A-2R) by CRISPR/Cas9 system
    Pan, Wenmin
    Yang, Yuhe
    Zhang, Shun
    Liu, Xiaoyu
    Hu, Huijuan
    Qu, Jia
    Liu, Hui
    STEM CELL RESEARCH, 2025, 84
  • [48] Generation of a USP9Y knockout human embryonic stem cell line with CRISPR-Cas9 technology
    Wei, Sai
    Zhen, Yuting
    Sun, Chao
    Ma, Yanlin
    Li, Qi
    Wen, Luan
    STEM CELL RESEARCH, 2025, 82
  • [49] Construction of a GLI3 compound heterozygous knockout human embryonic stem cell line WAe001-A-20 by CRISPR/Cas9 editing
    Wei, Ruzhi
    Yuan, Fang
    Wu, Yuhang
    Liu, Yanli
    You, Kai
    Yang, Zhen
    Chen, Yan
    Getachew, Anteneh
    Wang, Ning
    Xu, Yingying
    Zhuang, Yuanqi
    Yang, Fan
    Li, Yin-xiong
    STEM CELL RESEARCH, 2018, 32 : 139 - 144
  • [50] Generation of a PPP1CA knockout human pluripotent stem cell line via CRISPR/Cas9
    Wang, Xiaoman
    Sun, Jiaan
    Fu, Chong
    Liu, Chang
    STEM CELL RESEARCH, 2023, 69